|
1
|
Kahn BB: Type 2 diabetes: When insulin
secretion fails to compensate for insulin resistance. Cell.
92:593–596. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kahn SE, Hull RL and Utzschneider KM:
Mechanisms linking obesity to insulin resistance and type 2
diabetes. Nature. 444:840–846. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mayer-Davis EJ, D'Agostino R Jr, Karter
AJ, Haffner SM, Rewers MJ, Saad M and Bergman RN: Intensity and
amount of physical activity in relation to insulin sensitivity: The
insulin resistance atherosclerosis study. JAMA. 279:669–674. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaur J: A comprehensive review on
metabolic syndrome. Cardiol Res Pract. 2014:9431622014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ma YM, Tao RY, Liu Q, Li J, Tian JY, Zhang
XL, Xiao ZY and Ye F: PTP1B inhibitor improves both insulin
resistance and lipid abnormalities in vivo and in vitro. Mol Cell
Biochem. 357:65–72. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Seely BL, Staubs PA, Reichart DR, Berhanu
P, Milarski KL, Saltiel AR, Kusari J and Olefsky JM: Protein
tyrosine phosphatase 1B interacts with the activated insulin
receptor. Diabetes. 45:1379–1385. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knobler H and Elson A: Metabolic
regulation by protein tyrosine phosphatases. J Biomed Res.
28:157–168. 2014.PubMed/NCBI
|
|
8
|
Elchebly M, Payette P, Michaliszyn E,
Cromlish W, Collins S, Loy AL, Normandin D, Cheng A, Himms-Hagen J,
Chan CC, et al: Increased insulin sensitivity and obesity
resistance in mice lacking the protein tyrosine phosphatase-1B
gene. Science. 283:1544–1548. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Klaman LD, Boss O, Peroni OD, Kim JK,
Martino JL, Zabolotny JM, Moghal N, Lubkin M, Kim YB, Sharpe A, et
al: Increased energy expenditure, decreased adiposity, and
tissue-specific insulin sensitivity in protein-tyrosine phosphatase
1B-deficient mice. Mol Cell Biol. 20:5479–5489. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koren S and Fantus IG: Inhibition of the
protein tyrosine phosphatase PTP1B: Potential therapy for obesity,
insulin resistance and type-2 diabetes mellitus. Best Pract Res
Clin Endocrinol Metab. 21:621–640. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sun C, Zhang F, Ge X, Yan T, Chen X, Shi X
and Zhai Q: SIRT1 improves insulin sensitivity under
insulin-resistant conditions by repressing PTP1B. Cell Metab.
6:307–319. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Obanda DN and Cefalu WT: Modulation of
cellular insulin signaling and PTP1B effects by lipid metabolites
in skeletal muscle cells. J Nutr Biochem. 24:1529–1537. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Qiu SX and Shen XL: A hypoglycemic and
slimming stilbenoidal natureal medicine. CN Patent 101422450. Filed
October 9, 2008; issued May 6, 2009.
|
|
14
|
Cai JZ, Tang R, Ye GF, Qiu SX, Zhang NL,
Hu YJ and Shen XL: A Halogen-containing stilbene derivative from
the leaves of Cajanus cajan that induces osteogenic differentiation
of human mesenchymal stem cells. Molecules. 20:10839–10847. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yuan J, Lin J, Xu C, Ye Q, Xiong Y, Huang
L and Yuan H: Experimental research on prevention of
glucocorticoid-induced avascular necrosis of the femoral head with
tongluo shenggu capsule. Tradit Chin Drug Res Clin Pharmacol.
16:185–188. 2005.In Chinese.
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−delta delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
17
|
Samuel VT, Petersen KF and Shulman GI:
Lipid-induced insulin resistance: Unravelling the mechanism.
Lancet. 375:2267–2277. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nandi A, Kitamura Y, Kahn CR and Accili D:
Mouse models of insulin resistance. Physiol Rev. 84:623–647. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Duque-Guimaraes DE and Ozanne SE:
Nutritional programming of insulin resistance: Causes and
consequences. Trends Endocrinol Metab. 24:525–535. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Krook A, Wallberg-Henriksson H and Zierath
JR: Sending the signal: molecular mechanisms regulating glucose
uptake. Med Sci Sports Exerc. 36:1212–1217. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang S and Czech MP: The GLUT4 glucose
transporter. Cell Metab. 5:237–252. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lochhead P, Coghlan M, Rice S and
Sutherland C: Inhibition of GSK-3 selectively reduces
glucose-6-phosphatase and phosphatase and phosphoenolypyruvate
carboxykinase gene expression. Diabetes. 50:937–946. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Chi YJ, Li J, Guan YF and Yang JC:
PI3K/Akt signaling axis in regulation of glucose homeostasis. Chin
J Biochem Mol Biol. 26:879–885. 2010.In Chinese.
|
|
24
|
Bhattacharya S, Dey D and Roy SS:
Molecular mechanism of insulin resistance. J Biosci. 32:405–413.
2002. View Article : Google Scholar
|
|
25
|
Delibegovic M, Zimmer D, Kauffman C, Rak
K, Hong EG, Cho YR, Kim JK, Kahn BB, Neel BG and Bence KK:
Liver-specific deletion of protein-tyrosine phosphatase 1B (PTP1B)
improves metabolic syndrome and attenuates diet-induced endoplasmic
reticulum stress. Diabetes. 58:590–599. 2009. View Article : Google Scholar :
|
|
26
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cheng A, Uetani N, Simoncic PD, Chaubey
VP, Lee-Loy A, McGlade CJ, Kennedy BP and Tremblay ML: Attenuation
of leptin action and regulation of obesity by protein tyrosine
phosphatase 1B. Dev Cell. 2:497–503. 2002. View Article : Google Scholar
|
|
28
|
Bence KK, Delibegovic M, Xue B, Gorgun CZ,
Hotamisligil GS, Neel BG and Kahn BB: Neuronal PTP1B regulates body
weight, adiposity and leptin action. Nat Med. 12:917–924. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Goldstein BJ: Regulation of insulin
receptor signaling by protein-tyrosine dephosphorylation. Receptor.
3:1–15. 1993.PubMed/NCBI
|
|
30
|
Lee JE and Ge K: Transcriptional and
epigenetic regulation of PPARγ expression during adipogenesis. Cell
Biosci. 4:1–11. 2014. View Article : Google Scholar
|
|
31
|
Song DD, Chen Y, Li ZY, Guan YF, Zou DJ
and Miao CY: Protein tyrosine phosphatase 1B inhibits adipocyte
differentiation and mediates TNFα action in obesity. Biochim
Biophys Acta. 1831:1368–1376. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Gregoire FM, Smas CM and Sul HS:
Understanding adipocyte differentiation. Physiol Rev. 78:783–809.
1998. View Article : Google Scholar : PubMed/NCBI
|
